SrinivasVourgantiMD

Urology • Chicago, IL

Minimally Invasive Surgery, Surgical Oncology

Assistant Professor of Urology, Urologic Oncology, Rush University Medical Center

Join to view full profile

Dr. Vourganti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vourganti's full profile

Already have an account?

Office
1725 W Harrison St
Ste 970
Chicago, IL 60612
Phone+1 312-942-0713

Fax+1 312-563-3721

Summary

Dr. Srinivas Vourganti is a distinguished urologist (Urologic Oncologist) based in Chicago, Illinois. He specializes in robotic and minimally invasive urologic surgery, focusing on the treatment of cancers of the prostate, bladder, kidney, testes, adrenals, and ureter.

Dr. Vourganti completed his undergraduate training at the University of Michigan, and subsequently his medical degree at The Ohio State University College of Medicine. He then went on to complete his surgical and urology residencies in Cleveland at Case Western Reserve University Hospitals and at the Cleveland Clinic. He continued his training with fellowship at the National Cancer Institute of the National Institutes of Health, focusing on Urologic Oncology.

During his fellowship at the National Cancer Institute, Dr. Vourganti collaborated with world experts in clinical care, basic science, and engineering to develop new ideas and bring them to the clinic. He is particularly interested in refining translational imaging-based platforms as well as minimally invasive, image-targeted focal therapy.

His approach to medicine emphasizes a personalized approach and focuses on maintaining the delicate balance between aggressive treatment of cancer and maximizing the quality of life for his patients.

Education & Training

National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2010 - 2013
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2006 - 2010
Cleveland Clinic FoundationResidency, Urology, 2006 - 2007
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 2004 - 2006
Ohio State University College of MedicineClass of 2004
University of MichiganBS, Cellular and Molecular Biology, 1994 - 1998
Regents of The University of Michigan - Regional Alliance for HEAB.S., Cellular and Molecular Biology, With honors, 1994 - 1998

Certifications & Licensure

IL State Medical License 2016 - 2026
NY State Medical License 2013 - 2016
VA State Medical License 2010 - 2014
OH State Medical License 2004 - 2010
American Board of Urology Urology

Awards, Honors, & Recognition

Winning Abstract, "Treatment of Epstein-Barr Virus Transformed B-Cell Lines with the Histone Deacetylase Inhibitor Depsipeptide (FR901228) Results in the Induction of a Viral Thymidine Kinase and Enhanced Susceptibility to Antiviral-Induced Apoptosis" American College of Physicians, 2002
Winner Poster, "MRI Fusion Prostate Biopsy Outperforms 12-Core Systeatic Prostate Biopsy in Patients With Prior Negative Biopsy History: A Multi-institutional Analysis" American Urologic Association, 2016
Urology Medical Student Faculty Teaching Award SUNY Upstate, 2015
Best Presentation, "Multiparametric MRI and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients With Prior Negative Biopsies" American Urologic Association, 2012
Best Presentation, "PSA/SIA: Progress Report For A New Assay For Prostate Cancer" American Urologic Association, 2009
Winning Poster, "Prostate Specific Antigen/Solvent Interaction Analysis (PSA/SIA): A New Assay For Improved Prostate Cancer (CaP) Diagnosis" American Urologic Association, 2009
Honors Program in Surgery Ohio State University, 2003
Samuel J. Roessler Memorial Scholarship Award 2001
Bertha A. Bouroncle Research Fellowship Award 2000
Join now to see all

Clinical Trials

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance Start of enrollment: 2016 Jun 09
Completed
Phase 2
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue Start of enrollment: 2022 Mar 29
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

Predictors of delayed hospital discharge after robot-assisted partial nephrectomy: the impact of single-port robotic surgery.
Francesco Lasorsa, Angelo Orsini, Gabriele Bignante, Arianna Biasatti, Kyle A Dymanus
World Journal of Urology. 2024-12-13
The impact of single-port robotic surgery: a survey among urology residents and fellows in the United States.
Eugenio Bologna, Leslie Claire Licari, Ketan K Badani, Shirin Razdan, Sarah P Psutka
Journal of Robotic Surgery. 2024-10-14
Open versus Minimally Invasive Nephroureterectomy: Contemporary Analysis from a Wide National Population-Based Database.
Antonio Franco, Francesco Ditonno, Celeste Manfredi, Morgan R Sturgis, Eugenio Bologna
Annals of Surgical Oncology. 2024-10-01

Journal Articles

Chromophobe Renal Cell Carcinoma Is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database
Daugherty M, Blakely S, Shapiro O, Vourganti S, Mollapour M, Bratslavsky G, Journal of Urology, 1/1/2016
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells
Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN, Walton Diaz A, Chelluri R, Vourganti S, Trepel JB, Pinto PA, Journal of Urology, 1/1/2016
Pannus Is the New Prepuce? Penile Cancer in a Buried Phallus
Manwaring J, Vourganti S, Nikolavsky D, Valente AL, Byler T, Case Reports in Urology, 1/1/2015
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes
Martucci VL, Lorenzo ZG, Weintraub M, Del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K, Urologic Oncology, 1/1/2015
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without pr...
Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, P..., British Journal of Urology International, 1/1/2015
Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research
Vourganti S, Donaldson J, Johnson L, Turkbey B, Bratslavsky G, Kotula L, Experimental Biology and Medicine, 1/30/2014
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up
Rais-Bahrami S, Turkbey B, Rastinehad AR, Walton-Diaz A, Hoang AN, Siddiqui MM, Stamatakis L, Truong H, Nix JW, Vourganti S, Grant KB, Merino MJ, Choyke PL, Pinto PA, Diagnostic and Interventional Radiology, 1/1/2014
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session
Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Turkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA, Diagnostic and Interventional Radiology, 1/1/2014
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management
Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM, Journal of Clinical Oncology, 1/1/2014
Adverse health outcomes associated with surgical management of the small renal mass
Shuch B, Hanley JM, Lai JC, Vourganti S, Setodji CM, Dick AW, Chow WH, Saigal CS, Journal of Urology, 1/1/2014
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database
Vourganti S, Harbin A, Singer EA, Shuch B, Metwalli AR, Agarwal PK, Journal of Cancer, 1/6/2013
MRI characterization of the dynamic effects of 5alpha-reductase inhibitors on prostate zonal volumes
Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL,..., Canadian Journal of Urology, 1/1/2013
Estrogen receptor-Beta expression and pharmacological targeting in bladder cancer
Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ, Mongan NP, Oncology Reports, 1/1/2013
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?
Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T,Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C,Weintraub M, Chua C,..., Journal of Urology, 1/1/2013
Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy
Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, HoangAN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choy..., European Urology, 1/1/2013
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer
Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN,Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Journal of Urology, 1/1/2013
the Epidermal Growth Factor Receptor in Bladder Cancer
Weintraub MD, Vourganti S, Li Q, Apolo AB, Metwalli AR, Agarwal PK, Journal of Carcinogenesis & Mutagenes, 1/1/2013
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies
Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Krueker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA, Journal of Urology, 1/17/2012
Outcomes of Patients with Surgically Treated Bilateral Renal Masses and a Minimum of 10 Years of Followup
Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G, Journal of Urology, 1/17/2012
Age related changes in prostate zonal volume as measured by high resolution prostate MRI: a cross sectional study in over 500 patients
Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL, British Journal of Urology International, 1/14/2012
Image guidance in the focal treatment of prostate cancer
Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA, Current Opinion in Urology, 1/1/2012
Hinman’s Atlas of Urologic Surgery
Vourganti S, Ponsky LE, 1/1/2012
Hinman’s Atlas of Urologic Surgery
Vourganti S, Ponsky LE, 1/1/2012
Hinman’s Atlas of Urologic Surgery
Vourganti S, Ponsky LE, 1/1/2012
Targeting the mTOR pathway in Chromophobe Kidney Cancer
Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R, Journal of Cancer, 1/1/2012
Join now to see all

Books/Book Chapters

Surgical Techniques for Prostate Cancer
Chapter: Magnetic Resonance Imaging in Prostate Cancer Diagnosis
Page 15 - 20Vourganti S, Wojtowycz ASpringer2014

Abstracts/Posters

Multi-institutional Assessment of Multiparametric MRI and Fusion Biopsy of the Prostate in a Biopsy-Naïve Population
Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
MRI Fusion Prostate Biopsy Outperforms 12-Core Systeatic Prostate Biopsy in Patients With Prior Negative Biopsy History: A Multi-institutional Analysis
Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
High rates of metastatic disease in prostate cancer among BRCA2 mutation carriers: implications for screening
Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
Clinical Features Of Prostate Cancer In Confirmed Brca2+ Mutation Carriers
Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Quebec City, Quebec, 1/1/2015
Size Does Matter: Improving The Diagnostic Value Of Prostate Multiparametric MRI With The Consideration Of Lesion Volumes
Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Quebec City, Quebec, 1/1/2015
Can We Afford Prostate MRI, and Is it Worth it? – A Decision Analysis Comparing Cost Effectiveness of Systematic Transrectal Ultrasound Guided Biopsy and MRI–Ultrasoun...
Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Amelia Island, FL, 1/1/2014
Stromal testicular tumors exhibit worse cancer-specific survival compared to germ cell testicular tumors in all stage categories
Vourganti S, American Urologic Association National Meeting, Orlando, FL, 1/1/2014
Verification of Traditional Extended Systematic 12-Core TRUS Prostate Biopsy using Electromagnetic Tracking
Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2013
Multiparametric MRI and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients With Prior Negative Biopsies
Vourganti S, American Urologic Association National Meeting, Atlanta, GA, 1/1/2012
Low Suspicion Lesions On Multiparametric Magnetic Resonance Imaging Do Not Signify High Risk Cancer
Vourganti S, American Urologic Association National Meeting, Atlanta, GA, 1/1/2012
Verification of Traditional Extended Systematic 12-Core TRUS Prostate Biopsy using Electromagnetic Tracking
Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2012
Low Grade Micropapillary Urothelial Carcinoma – Does It Exist? - A SEER Analysis of Management and Outcomes
Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2012
Comparison of Partial Nephrectomy for Tumors Greater Than 7 cm to Radical Nephrectomy and Effect on Overall Survival
Vourganti S, American Society of Clinical Oncology – Genitourinary Cancer Meeting, Orlando, FL, 1/1/2011
Role of heat shock protein 90 inhibition with 17-(allylamino)-17 (demethoxygeldenamycin) in muscle-invasive bladder cancer cells
Vourganti S, American Society of Clinical Oncology – Genitourinary Cancer Meeting, Orlando, FL, 1/1/2011
PSA/SIA: Progress Report For A New Assay For Prostate Cancer
Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
Use of 5-Alpha Reductase Inhibitors In Treatment of Biochemical Failure Following Radical Prostatectomy Following Radical Prostatectomy in Sexually Active Patients
Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
Metastatic Prostate Cancer as the Initial Diagnosis in the PSA Era
Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
Prostate Specific Antigen/Solvent Interaction Analysis (PSA/SIA): A New Assay For Improved Prostate Cancer (CaP) Diagnosis
Vourganti S, American Urologic Association National Meeting; American Society of Clinical Oncology National Meeting, Orlando, FL, 1/1/2009
Is a positive surgical margin important following nephron sparing surgery?
Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2008
Treatment of Epstein-Barr Virus Transformed B-Cell Lines with the Histone Deacetylase Inhibitor Depsipeptide (FR901228) Results in the Induction of a Viral Thymidine K...
Vourganti S, American College of Physicians Annual Meeting, Philadelphia, PA
Join now to see all

Lectures

Debate: Ultrasound-MRI Fusion Guided Biopsy vs. Transperineal Approach
Buenos Aires, Argentina - 1/1/2016
MR/US Fusion-Guided Prostate Biopsy: Beginner and Advanced Techniques
Chicago, IL - 1/1/2016
The Expanding Role of Partial Prostate Gland Ablation (Focal Therapy) in the Era of Imaging Based Prostate Cancer Management
Chattanooga, TN - 1/1/2016
Magnetic Resonance Imaging in Prostate Cancer Diagnosis
Multiple locations, 2014, 2015, 2016 - 1/1/2016
Rationale of MRI/US Fusion Biopsy in Active Surveillance of Prostate Cancer
Linthicum, MD - 1/1/2016
Troubleshooting common problems in Uronav Fusion prostate biopsy
Linthicum, MD - 1/1/2016
Master Class: Prostate Cancer Biopsies – Current Concepts
Buenos Aires, Argentina - 1/1/2016
Latest Advances in Prostate Fusion Biopsy
New Orleans, LA - 1/1/2015
Cost of Prostate MRI-US Fusion– A Decision Analysis comparing cost effectiveness of Systematic Transrectal Ultrasound Guided Biopsy and MRI-Ultrasound Fusion Prostate ...
New Orleans, LA - 1/1/2015
The Evolving Role of Magnetic Resonance Imaging in Prostate Cancer Diagnosis
Burlington, VT - 1/1/2014
MRI/Ultrasound Image Fusion in the Diagnosis & Treatment of Prostate Cancer
Rochester, NY - 1/1/2014
Rationale of Focal Therapy of Prostate Cancer
Saratoga Springs, NY - 1/1/2013
Outcomes of Patients with Surgically Treated Bilateral Renal Masses and a Minimum of 10 Years of Follow-up: The NCI Experience
Washington, DC - 1/1/2011
Focal Cryoablation for Low Risk Prostate Cancer: Preliminary Observations
Chicago, IL - 1/1/2010
Patient Reported Outcomes With Vacuum Erection Device For Erectile Dysfunction
Scottsdale, AZ - 1/1/2009
Abnormal Bone Mineral Density in Men with Symptomatic Hypogonadism
Orlando, FL - 1/1/2008
The Impact of Primary Tumor Anatomic Location on Aggressive Disease Behavior of Localized Renal Cell Carcinoma
Sandusky, OH - 1/1/2008
Join now to see all

Other

Hydronephrosis and Hydroureter
Vourganti S, Maniam P, Resnick MI, eMedicine
http://www.emedicine.com/ED/topic1055.htm
1/1/2008

Authored Content

Fusion Prostate Biopsy Outperforms 12-Core Systematic Prostate Biopsy in Patients with Prior Negative Systematic Biopsy: A Multi-Institutional AnalysisMay 2018